Physician profile
Daniel E Mckenna
NPI 1497770598
$3,016.67
in general payments reported to CMS, 2019-2025
18 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $19.73 · 2021: $1,849 · 2022: $450 · 2023: $126 · 2024: $221 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Theater. INC. | $1,331.79 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $241.08 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $177.32 | 2019-2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Abbott Laboratories | $137.88 | 2022 | |
| Genzyme Corporation | $124.29 | 2021 | |
| Alexion Pharmaceuticals, INC. | $121.52 | 2025 | Koselugo |
| Pharming Healthcare, INC. | $121.38 | 2024 | Joenja |
| Rhythm Pharmaceuticals, INC. | $111.65 | 2021 | |
| Travere Therapeutics, INC. | $105.00 | 2022 | |
| Kyowa Kirin, INC. | $99.59 | 2024 | |
| Phadia US INC. | $90.60 | 2021 | |
| Mirum Pharmaceuticals, INC. | $85.86 | 2023 | Livmarli |
| Ultragenyx Pharmaceutical INC. | $85.01 | 2022 | |
| Getinge USA Sales, LLC | $71.05 | 2021 | |
| Ptc Therapeutics, INC. | $51.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| B. Braun Interventional Systems INC. | $24.98 | 2023 | Cp Stent |
| Hitachi Healthcare Americas Corp. | $19.73 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.